Some gene therapies no longer require clinical trials, thanks to new FDA rule. Is this safe, and who will it help?

The FDA is launching a new framework to deliver tailor-made gene therapies to people with rare genetic disorders. Discussions about whom to treat and how to monitor patients are ongoing.